Immunohistochemistry in a Spindle Cell Lesion: A Case of Cellular Dermatofibroma
Abstract
Cellular dermatofibroma (CDF) is an uncommon hyper-cellular variant of benign fibrous histiocytoma that may clinically and histo-pathologically mimic malignant spindle cell neoplasms, particularly dermatofibrosarcoma protuberans (DFSP) and spindle cell squamous cell carcinoma (SpSCC). Accurate distinction is essential because these entities differ substantially in biological behaviour, therapeutic management, and prognosis. This study reports a diagnostically challenging case of CDF in a 56-year-old woman presenting with a gradually enlarging keratotic nodule over the extensor aspect of the left forearm. Clinically, the lesion resembled keratoacanthoma, while preliminary histopathological evaluation suggested a spindle cell neoplasm. Histopathological examination revealed a hypercellular dermal spindle cell proliferation arranged in fascicular and focal storiform patterns without significant atypia, necrosis, or atypical mitoses. No honeycomb infiltration of subcutaneous fat was identified. Immunohistochemistry demonstrated negativity for CD34, AE1/AE3, STAT6, SOX10, desmin, smooth muscle actin, caldesmon, calponin, and ERG, with focal S100 positivity. Excision followed by histopathological examinations such as correlation of histomorphological and immunophenotypic findings revealed a well-circumscribed, densely cellular dermal spindle cell lesion, and immunohistochemistry confirmed a diagnosis of cellular dermatofibroma (CD34, Pan-cytokeratin negative). This case highlights the diagnostic utility of immunohistochemistry in the evaluation of cutaneous spindle cell lesions and emphasises the importance of distinguishing CDF from malignant mimickers to prevent unnecessary aggressive surgical management.
Full text article
References
References
Myers DJ, Fillman EP. Dermatofibroma. StatPearls. Treasure Island: StatPearls Publishing; 2024.
Han TY, Chang HS, Lee JH, Lee WM, Son SJ. A clinical and histopathological study of 122 cases of dermatofibroma. Ann Dermatol 2011; 23:185-92.
Alves JV, Matos DM, Barreiros HF, Bártolo EA. Variants of dermatofibroma: A histopathological study. An Bras Dermatol 2014;89:472-7.
Calonje E. Cutaneous fibrohistiocytic tumours: An update. Histopathology 2010;56:148-65.
Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Am J Surg Pathol 1994;18:668-76.
Reha J, Reed K. Diagnostic approach to spindle cell neoplasms. Arch Pathol Lab Med 2020;144:823-36.
Fetsch JF, Laskin WB, Miettinen M. CD34 expression in dermatofibroma and dermatofibrosarcoma protuberans. Mod Pathol 1999;12:660-6.
Llombart B, Serra-Guillén C, Guerrero L, et al. Dermatofibrosarcoma protuberans: A comprehensive review and update on diagnosis and management. Actas Dermosifiliogr 2019;110:614-25.
Rodriguez F, Weiss SW. S-100 protein expression in dermatofibromas. Am J Dermatopathol 1993;15:450-4.
Cassarino DS, DeBloom JR. Spindle cell squamous cell carcinoma: A review of diagnostic advances and differential diagnosis. Adv Anat Pathol 2013;20:203-11.
Doyle LA, Vivero M, Fletcher CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumour from histologic mimics. Mod Pathol 2014;27:390-5.
Santa Cruz DJ, Kyriakos M. Aneurysmal fibrous histiocytoma of the skin. Cancer 1981;47:2053-61.
Jones EW, Cerio R, Smith NP. Epithelioid cell histiocytoma: A clinicopathological analysis. Br J Dermatol 1989;120:185-95.
Iwata J, Fletcher CD. Lipidized fibrous histiocytoma: Clinicopathologic analysis of cases. Am J Dermatopathol 2000;22:126-34.
Zelger BW, Steiner H, Kutzner H. Clear cell dermatofibroma. Am J Surg Pathol 1996;20:483-91.
Gaufin M, Michaelis T, Duffy K. Cellular dermatofibroma: clinicopathologic review of 218 cases of cellular dermatofibroma to determine the clinical recurrence rate. Dermatol Surg. 2019;45(11):1359-1364.
Siegel DR, Schneider SL, Chaffins M, Rambhatla PV. A retrospective review of 93 cases of cellular dermatofibromas. Int J Dermatol. 2020;59(2):229-235.
Le NT, Eisen DB. Clinical and histopathologic characteristics and outcomes of cellular dermatofibroma: a retrospective observational study of 29 patients. JAAD Int. 2025;19:43-44.
Elbendary A, Griffin JR, Elston DM, Verma SB. Cellular dermatofibroma: a hyperkeratotic indurated plaque on the thigh. Indian Dermatol Online J. 2016;7(4):308-310.
Kimyai-Asadi A, Goldberg LH, Greenberg C, Jih MH. Cellular, atypical, and indeterminate dermatofibromas: benign or malignant? Dermatol Surg. 2008;34(9):1264-1270.
Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol. 1993;15(5):429-434.
Sachdev R, Sundram U. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and factor XIIIa. J Cutan Pathol. 2006;33(5):353-360.
Hui P, Glusac EJ, Sinard JH, Perkins AS. Clonal analysis of cutaneous fibrous histiocytoma. J Cutan Pathol.2002;29(7):385-389.
Chen TC, Kuo TT, Chan HL. Dermatofibroma is a clonal proliferative disease. J Cutan Pathol. 2000;27(1):36-39.
Zelger BG, Steiner H, Kutzner H, Maier H, Zelger B. Cellular neurothekeoma: an epithelioid variant of dermatofibroma? Histopathology. 1998;32(5):414-422.
Authors
Copyright (c) 2026 Sangeeta Mitra, Ruben Bhasin, Shama Naaz

This work is licensed under a Creative Commons Attribution 4.0 International License.